The anti-invasive effect of lucidenic acids isolated from a new Ganoderma lucidum strain

Molecular Nutrition and Food Research

Volumn 51, Issue 12, 2007, Pages 1472-1477

  Weng, Chia Jui ^a   Chau, Chi Fai ^a   Chen, Kuang Dee ^b   Chen, Deng Hai ^b   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b Double Crane Group   (Taiwan)

Author keywords

Anti invasion; Ganoderma lucidum; HepG2 cells; Lucidenic acid; MMP 9 activity

Indexed keywords

CHOLIC ACID DERIVATIVE; GELATINASE B; LUCIDENIC ACID A; LUCIDENIC ACID B; LUCIDENIC ACID C; LUCIDENIC ACID N; PHORBOL 13 ACETATE 12 MYRISTATE; TERPENE; TRITERPENE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CHEMISTRY; DRUG ANTAGONISM; GANODERMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHOLIC ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GANODERMA; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; TERPENES; TETRADECANOYLPHORBOL ACETATE; TRITERPENES;

BASIDIOMYCOTA; GANODERMA LUCIDUM;

EID: 38049016812     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700155     Document Type: Article

References (22)

1. Weiss, L., Metastatic inefficiency, Adv. Cancer Res. 1990, 54, 159-211.
2. Liotta, L. A., Steeg, P. S., Stetter-Stevenson, W. G., Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation, Cell 1991, 64, 327-336.
3. Condeelis, J., Segall, J. E., Intravital imaging of cell movement in tumours, Nat. Rev. Cancer 2003, 3, 921-930.
4. Teow, S. S., in: Kim, B. K., Moon, C. K., Kim, T. S. (Eds.), Recent Progress in Ganoderma lucidum Research, The Pharmaceutical Society of Korea, Seoul 1997, 21-39.
5. Hsieh, C., Yang, F. C., Reusing soy residue for the solidstate fermentation of Ganoderma lucidum, Bioresource Technol. 2004, 91, 105-109.
6. Song, Y. S., Kim, S. H., Sa, J. H., Jin, C., et al., Antiangiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum, J. Ethnophamacol. 2004, 90, 17-20.
7. Wang, Y. Y., Khoo, K. H., Chen, S. T., Lin, C. C., et al., Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides: Functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities, Bioorgan. Med. Chem. 2002, 10, 1057-1062.
8. Hyun, J. W., Choi, E. C., Kim, B. K., Studies on constituents of higher fungi of Korea IXII. Antitumor components of the basidiocarp of Ganoderma lucidum, Korean J. Mycol. 1990, 18, 58-69.
9. Yang, H. L., Zhang, K. C., The relationship between molecular structure and activity of Ganoderma acids, J. Wux.i Univ. Light Ind. 2002, 21, 249-253 (in Chinese with an English abstract).
10. Chen, D. H., Shiou, W. Y, Wang, K. C., Huang, S. Y, et al., Chemotaxonomy of Triterpenoid pattern of HPLC of Ganoderma lucidum and Ganoderma tsugae, J. Chin. Chem. Soc. 1999, 46, 47-51.
11. Repesh, L. A., A new in vitro assay for quantitating tumor cell invasion, Invas. Metast. 1989, 9, 192-208.
12. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 1976, 72, 248-254.
13. 30 triterpenoids form the fungus Ganoderma lucidum (Reishi), Agric. Biol. Chem. 1985, 49, 1793-1798.
14. Wu, T. S., Shi, L. S., Kuo, S. C., Cytotoxicity of Ganoderma lucidum triterpenes, J. Nat. Prod. 2001, 64, 1121-1122.
15. Newton, A. C., Regulation of protein kinase C, Curr. Opin. Cell. Biol. 1997, 9, 161-167.
16. Liu, P., Kimmoun, E., Legrand, A., Sauvanet, A., et al., Activation of NF-kB, AP-1, and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas, J. Hepatol. 2002, 37, 63-71.
17. Juarez, J., Clayman, G., Nakajima, M., Tanabe, K. K., et al., Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cel carcinoma cell lines of the oral cavity, Int. J. Cancer 1993, 55, 10-18.
18. Liu, G. Q., Zhang, K. C., Mechanisms of the anticancer action of Ganoderma lucidum (Leyss. Ex Fr.) Karst.: A new understanding, J. Integrative Plant Biol. 2005, 47, 129-135.
19. Kimura, Y., Taniguchi, M., Baba, K., Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum, mechanism of action and isolation of an active substance, Anticancer Res. 2002, 22, 3309-3318.
20. Scorilas, A., Karameris, A., Arnogiannaki, N., Ardavanis, A. et al., Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients, Br. J. Cancer 2001, 84, 1488-1496.
21. Chu, S. C., Chiou, H. L., Chen, P. N., Yang, S. F., Hsieh, Y. S., Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2, Mol. Carcinog. 2004, 40, 143-149.
22. Wang, A. C., Li, B., Ganoderma, Beijing Science and Technology Press, Beijing 2002 (in Chinese).